Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,543 | 174 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,070 | 43 | $0 (2024) |
| Amgen Inc. | $875.55 | 44 | $0 (2024) |
| PFIZER INC. | $243.51 | 13 | $0 (2021) |
| GlaxoSmithKline, LLC. | $163.39 | 11 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $160.68 | 8 | $0 (2022) |
| Allergan Inc. | $158.33 | 10 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $152.71 | 9 | $0 (2024) |
| AbbVie Inc. | $122.92 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $80.05 | 4 | $0 (2021) |
| Exact Sciences Corporation | $77.85 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.13 | 13 | Exact Sciences Corporation ($62.18) |
| 2023 | $262.36 | 14 | Novo Nordisk Inc ($86.12) |
| 2022 | $438.82 | 25 | Novo Nordisk Inc ($126.92) |
| 2021 | $920.04 | 39 | Novo Nordisk Inc ($429.41) |
| 2020 | $475.51 | 22 | Amgen Inc. ($245.50) |
| 2019 | $303.85 | 14 | Novo Nordisk Inc ($133.85) |
| 2018 | $455.70 | 22 | Amgen Inc. ($165.76) |
| 2017 | $410.21 | 25 | Amgen Inc. ($104.28) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardio-renal | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.08 | General |
| 06/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $38.56 | General |
| Category: Endocrinology | ||||||
| 06/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.85 | General |
| 05/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Oncology | ||||||
| 04/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Oncology | ||||||
| 02/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 01/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Omeza LLC | — | Food and Beverage | Cash or cash equivalent | $31.11 | General |
| 10/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Oncology | ||||||
| 09/07/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Inflammation | ||||||
| 08/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: KRYSTEXXA | ||||||
| 06/06/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 05/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 04/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardio-renal | ||||||
| 04/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
| 01/31/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 01/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 373 | 1,071 | $131,551 | $61,239 |
| 2022 | 9 | 383 | 1,216 | $134,454 | $69,531 |
| 2021 | 11 | 449 | 1,291 | $138,986 | $66,485 |
| 2020 | 11 | 540 | 1,542 | $162,185 | $67,633 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 65 | 518 | $38,850 | $24,033 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 141 | $31,725 | $13,018 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 120 | $18,200 | $7,445 | 40.9% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 36 | 46 | $11,500 | $4,663 | 40.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 94 | $11,750 | $3,491 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $4,906 | $3,253 | 66.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 29 | 31 | $4,030 | $2,018 | 50.1% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 22 | 24 | $3,360 | $1,753 | 52.2% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 35 | 42 | $5,880 | $1,071 | 18.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $1,350 | $492.75 | 36.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 67 | 647 | $46,710 | $28,438 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 135 | $30,375 | $13,251 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 154 | $23,100 | $10,737 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $7,359 | $5,417 | 73.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 85 | $10,625 | $3,658 | 34.4% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 41 | 46 | $6,440 | $3,515 | 54.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 44 | 47 | $6,110 | $3,198 | 52.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 25 | 25 | $1,985 | $664.76 | 33.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 35 | 35 | $1,750 | $651.57 | 37.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 76 | 630 | $37,865 | $18,839 | 49.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 130 | $29,250 | $13,114 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 159 | $23,850 | $10,655 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $7,885 | $6,042 | 76.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 38 | 126 | $15,750 | $4,939 | 31.4% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 49 | 58 | $8,120 | $4,530 | 55.8% |
About Dr. Indira Devu, MD
Dr. Indira Devu, MD is a Internal Medicine healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871530139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Indira Devu, MD has received a total of $3,543 in payments from pharmaceutical and medical device companies, with $276.13 received in 2024. These payments were reported across 174 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,543).
As a Medicare-enrolled provider, Devu has provided services to 1,745 Medicare beneficiaries, totaling 5,120 services with total Medicare billing of $264,888. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Marietta, GA
- Active Since 06/02/2006
- Last Updated 09/15/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871530139
Products in Payments
- Aimovig (Biological) $460.49
- Ozempic (Drug) $363.65
- Tresiba (Drug) $212.24
- Prolia (Biological) $204.49
- VRAYLAR (Drug) $187.05
- CHANTIX (Drug) $117.25
- Otezla (Drug) $115.44
- RYBELSUS (Drug) $114.55
- BREZTRI (Drug) $97.85
- SOLIQUA 100/33 (Biological) $87.35
- Vascepa (Drug) $80.05
- Cologuard Collection Kit (Device) $77.85
- ANORO (Drug) $73.60
- PRALUENT (Drug) $73.33
- Rybelsus (Drug) $71.64
- Kerendia (Drug) $67.29
- Repatha (Biological) $59.11
- Victoza (Drug) $58.88
- JYNARQUE (Drug) $55.63
- KRYSTEXXA (Biological) $50.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marietta
Dr. Mohammed Abubaker, Md, MD
Internal Medicine — Payments: $404,639
Ahmed Al-Badri, Md, MD
Internal Medicine — Payments: $88,349
Dr. Amyn Hirani, M.d, M.D
Internal Medicine — Payments: $68,603
Dr. Shinoj Pattali Jayavalsan, M.d, M.D
Internal Medicine — Payments: $18,051
Mrs. Lisa Lefkovits, Md, MD
Internal Medicine — Payments: $14,823
Dr. David Cantrell, Md, MD
Internal Medicine — Payments: $14,474